603858.SS · 步长制药
China A-shares · RS rating 53 · As of 2026-10-14
| Price | 14.60 CNY |
|---|---|
| 1-day change | -0.1% |
| RS rating (overall / 1M / 3M / 12M) | 53 / 71 / 38 / 40 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 27 / 32 / 24 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -6.0% |
| Distance from 52-week high | +21.6% |
| Market cap (USD) | $2.3B |